Robin L Smith Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Robin L Smith.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Robin L Smith. Robin L Smith is Chairman and CEO in Caladrius Biosciences, Inc. ($NBS) and Executive Chair of the Board in Caladrius Biosciences, Inc. ($NBS) and Director in SEELOS THERAPEUTICS, INC. ($APRI) and Director in ROCKWELL MEDICAL, INC. ($RMTI) and Director in MYnd Analytics, Inc. ($CNSO) and Director in SERVICESOURCE INTERNATIONAL, INC. ($SREV) and Director in Sorrento Therapeutics, Inc. ($SRNE) and Director in PROLUNG INC ($FRES) and Director in SIGNAL GENETICS, INC. ($SGNL).
Latest Insider Trading Transactions of Robin L Smith
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, NBS, MYND, LUNG, RMTI, SEEL, SREV, SRNE, MGEN
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jun 15 2020 | SRNE | Sorrento Therapeut ... | Smith Robin L | Director | Option Exercise | A | 4.89 | 100,000 | 489,000 | 100,000 | |
| May 21 2020 | SREV | SERVICESOURCE INTE ... | Smith Robin L | Director | Buy | P | 1.70 | 50,000 | 85,000 | 167,975 | 118 K to 168 K (+42.38 %) |
| May 14 2020 | SREV | SERVICESOURCE INTE ... | Smith Robin L | Director | Grant | A | 0.00 | 100,000 | 0 | 117,975 | 18 K to 118 K (+556.33 %) |
| Mar 06 2020 | SREV | SERVICESOURCE INTE ... | Smith Robin L | Director | Grant | A | 0.00 | 17,975 | 0 | 17,975 | 0 to 18 K |
| Mar 05 2020 | SRNE | Sorrento Therapeut ... | Smith Robin L | Director | Buy | P | 2.27 | 40,000 | 90,896 | 60,000 | 20 K to 60 K (+200.00 %) |
| Jan 07 2020 | SEEL | SEELOS THERAPEUTIC ... | Smith Robin L | Director | Option Exercise | A | 1.42 | 16,000 | 22,720 | 16,000 | |
| Dec 18 2019 | SRNE | Sorrento Therapeut ... | Smith Robin L | Director | Option Exercise | A | 3.95 | 75,000 | 296,250 | 75,000 | |
| Jun 10 2019 | RMTI | ROCKWELL MEDICAL, ... | Smith Robin L | Director | Option Exercise | A | 4.15 | 22,461 | 93,213 | 22,461 | |
| Jun 10 2019 | RMTI | ROCKWELL MEDICAL, ... | Smith Robin L | Director | Grant | A | 0.00 | 21,566 | 0 | 31,366 | 9.8 K to 31.4 K (+220.06 %) |
| May 10 2019 | MYND | MYnd Analytics, In ... | Smith Robin L | Director | Option Exercise | A | 1.19 | 100,000 | 119,000 | 100,000 | |
| May 10 2019 | MYND | MYnd Analytics, In ... | Smith Robin L | Director | Grant | A | 1.19 | 50,000 | 59,500 | 211,539 | 161.5 K to 211.5 K (+30.95 %) |
| Mar 21 2019 | APRI | SEELOS THERAPEUTIC ... | Smith Robin L | Director | Option Exercise | A | 2.33 | 16,000 | 37,280 | 16,000 | |
| Mar 21 2019 | APRI | SEELOS THERAPEUTIC ... | Smith Robin L | Director | Option Exercise | A | 2.33 | 24,000 | 55,920 | 24,000 | |
| Oct 10 2018 | MYAN | MYnd Analytics, In ... | Smith Robin L | Director | Option Exercise | A | 1.38 | 48,000 | 66,240 | 48,000 | |
| Sep 25 2018 | MYAN | MYnd Analytics, In ... | Smith Robin L | Director | Option Exercise | A | 2.00 | 13,513 | 27,026 | 13,513 | |
| Sep 25 2018 | MYAN | MYnd Analytics, In ... | Smith Robin L | Director | Option Exercise | A | 2.00 | 13,513 | 27,026 | 13,513 | |
| Sep 25 2018 | MYAN | MYnd Analytics, In ... | Smith Robin L | Director | Grant | A | 1.85 | 13,513 | 24,999 | 161,539 | 148 K to 161.5 K (+9.13 %) |
| Sep 25 2018 | MYAN | MYnd Analytics, In ... | Smith Robin L | Director | Grant | A | 1.85 | 13,513 | 24,999 | 161,539 | 148 K to 161.5 K (+9.13 %) |
| May 14 2018 | FRES | PROLUNG INC | Smith Robin L | Director | Option Exercise | A | 8.00 | 7,320 | 58,560 | 7,320 | |
| Apr 20 2018 | MYAN | MYnd Analytics, In ... | Smith Robin L | Director | Option Exercise | A | 1.99 | 150,000 | 298,500 | 150,000 | |
| Apr 20 2018 | MYAN | MYnd Analytics, In ... | Smith Robin L | Director | Option Exercise | A | 1.55 | 75,000 | 116,250 | 75,000 | |
| Apr 20 2018 | MYAN | MYnd Analytics, In ... | Smith Robin L | Director | Grant | A | 0.00 | 25,000 | 0 | 148,026 | 123 K to 148 K (+20.32 %) |
| Mar 21 2018 | RMTI | ROCKWELL MEDICAL, ... | Smith Robin L | Director | Option Exercise | A | 5.75 | 38,985 | 224,164 | 38,985 | |
| Nov 20 2017 | MYAN | MYnd Analytics, In ... | Smith Robin L | Director | Grant | A | 0.00 | 7,500 | 0 | 123,026 | 115.5 K to 123 K (+6.49 %) |
| Aug 30 2017 | FRES | PROLUNG INC | Smith Robin L | Director | Option Exercise | A | 1.25 | 70,000 | 87,500 | 70,000 | |
| Aug 30 2017 | FRES | PROLUNG INC | Smith Robin L | Director | Option Exercise | A | 1.00 | 30,000 | 30,000 | 30,000 | |
| Aug 30 2017 | FRES | PROLUNG INC | Smith Robin L | Director | Option Exercise | A | 1.00 | 20,000 | 20,000 | 20,000 | |
| Aug 23 2017 | MYAN | MYnd Analytics, In ... | Smith Robin L | Director | Option Exercise | A | 4.16 | 50,000 | 208,000 | 50,000 | |
| Aug 23 2017 | MYAN | MYnd Analytics, In ... | Smith Robin L | Director | Option Exercise | A | 4.33 | 75,000 | 324,750 | 75,000 | |
| Aug 10 2017 | MYAN | MYnd Analytics, In ... | Smith Robin L | Director | Option Exercise | A | 6.00 | 8,000 | 48,000 | 40,000 | |
| Jul 18 2017 | MYAN | MYnd Analytics, In ... | Smith Robin L | Director | Option Exercise | A | 6.00 | 8,000 | 48,000 | 32,000 | |
| Jul 18 2017 | MYAN | MYnd Analytics, In ... | Smith Robin L | Director | Option Exercise | A | 6.00 | 8,000 | 48,000 | 24,000 | |
| Jul 18 2017 | MYAN | MYnd Analytics, In ... | Smith Robin L | Director | Grant | A | 0.00 | 25,000 | 0 | 115,526 | 90.5 K to 115.5 K (+27.62 %) |
| Jun 14 2017 | FRES | PROLUNG INC | Smith Robin L | Director | Grant | A | 0.00 | 30,000 | 0 | 30,000 | 0 to 30 K |
| Mar 23 2017 | RMTI | ROCKWELL MEDICAL, ... | Smith Robin L | Director | Grant | A | 0.00 | 9,800 | 0 | 9,800 | 0 to 9.8 K |
| Feb 07 2017 | SGNL | SIGNAL GENETICS, I ... | Smith Robin L | Director | Option Exercise | M | 7.65 | 1,200 | 9,180 | 0 | |
| Feb 07 2017 | SGNL | SIGNAL GENETICS, I ... | Smith Robin L | Director | Buy | M | 7.65 | 1,200 | 9,180 | 1,900 | 700 to 1.9 K (+171.43 %) |
| Dec 14 2016 | CNSO | MYnd Analytics, In ... | Smith Robin L | Director | Buy | P | 6.00 | 5,000 | 30,000 | 90,526 | 85.5 K to 90.5 K (+5.85 %) |
| Dec 02 2016 | CNSO | MYnd Analytics, In ... | Smith Robin L | Director | Grant | A | 6.25 | 16,000 | 100,000 | 85,526 | 69.5 K to 85.5 K (+23.01 %) |
| Nov 02 2016 | CNSO | MYnd Analytics, In ... | Smith Robin L | Director | Option Exercise | A | 6.00 | 16,000 | 96,000 | 16,000 | |
| Nov 02 2016 | CNSO | MYnd Analytics, In ... | Smith Robin L | Director | Grant | A | 0.00 | 40,000 | 0 | 69,526 | 29.5 K to 69.5 K (+135.47 %) |
| Sep 23 2016 | RMTI | ROCKWELL MEDICAL, ... | Smith Robin L | Director | Option Exercise | A | 6.55 | 25,000 | 163,750 | 25,000 | |
| Sep 23 2016 | CNSO | MYnd Analytics, In ... | Smith Robin L | Director | Buy | M | 5.00 | 20,776 | 103,880 | 29,526 | 8.8 K to 29.5 K (+237.44 %) |
| Jun 20 2016 | SGNL | SIGNAL GENETICS, I ... | Smith Robin L | Director | Option Exercise | A | 0.51 | 18,000 | 9,180 | 18,000 | |
| Apr 07 2016 | CNSO | MYnd Analytics, In ... | Smith Robin L | Director | Grant | A | 0.00 | 1,000,000 | 0 | 1,750,000 | 750 K to 1.8 M (+133.33 %) |
| Apr 25 2016 | CNSO | MYnd Analytics, In ... | Smith Robin L | Director | Option Exercise | A | 0.05 | 800,000 | 40,000 | 2,000,000 | |
| Dec 28 2015 | CNSO | MYnd Analytics, In ... | Smith Robin L | Director | Option Exercise | A | 0.05 | 1,200,000 | 60,000 | 1,200,000 | |
| Aug 24 2015 | CNSO | MYnd Analytics, In ... | Smith Robin L | Director | Option Exercise | A | 0.06 | 250,000 | 13,750 | 250,000 | |
| Aug 24 2015 | CNSO | MYnd Analytics, In ... | Smith Robin L | Director | Grant | A | 0.00 | 750,000 | 0 | 750,000 | 0 to 750 K |
| Aug 10 2015 | SGNL | SIGNAL GENETICS, I ... | Smith Robin L | Director | Option Exercise | A | 1.62 | 18,000 | 29,160 | 18,000 | |
| Aug 10 2015 | SGNL | SIGNAL GENETICS, I ... | Smith Robin L | Director | Option Exercise | M | 0.00 | 4,125 | 0 | 0 | |
| Aug 10 2015 | SGNL | SIGNAL GENETICS, I ... | Smith Robin L | Director | Grant | A | 0.00 | 5,000 | 0 | 10,500 | 5.5 K to 10.5 K (+90.91 %) |
| Aug 10 2015 | SGNL | SIGNAL GENETICS, I ... | Smith Robin L | Director | Buy | M | 0.00 | 4,125 | 0 | 5,500 | 1.4 K to 5.5 K (+300.00 %) |
| Jul 21 2015 | SGNL | SIGNAL GENETICS, I ... | Smith Robin L | Director | Option Exercise | M | 0.00 | 1,375 | 0 | 4,125 | |
| Jul 21 2015 | SGNL | SIGNAL GENETICS, I ... | Smith Robin L | Director | Buy | M | 0.00 | 1,375 | 0 | 1,375 | 0 to 1.4 K |
| Jun 04 2015 | NBS | Caladrius Bioscien ... | Smith Robin L | Executive Chair of ... | Grant | A | 0.00 | 40,000 | 0 | 347,285 | 307.3 K to 347.3 K (+13.02 %) |
| Jun 06 2006 | NBS | Caladrius Bioscien ... | Smith Robin L | Chairman and CEO | Option Exercise | P | 0.08 | 250,000 | 20,000 | 250,000 | |
| Jun 06 2006 | NBS | Caladrius Bioscien ... | Smith Robin L | Chairman and CEO | Option Exercise | A | 0.00 | 5,400,000 | 0 | 5,400,000 | |
| Jun 06 2006 | NBS | Caladrius Bioscien ... | Smith Robin L | Chairman and CEO | Buy | P | 0.04 | 500,000 | 22,000 | 4,000,000 | 3.5 M to 4 M (+14.29 %) |
| Jun 06 2006 | NBS | Caladrius Bioscien ... | Smith Robin L | Chairman and CEO | Grant | A | 0.00 | 1,000,000 | 0 | 3,500,000 | 2.5 M to 3.5 M (+40.00 %) |
| Jun 06 2006 | NBS | Caladrius Bioscien ... | Smith Robin L | Chairman and CEO | Grant | A | 0.00 | 2,000,000 | 0 | 2,500,000 | 500 K to 2.5 M (+400.00 %) |
Page: 1